Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 2125 of 2400 entries
View as:

Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00101374 Org: User:
Start: 01/05/05 End: 05/21/08 Due: 05/21/09

The Biology of HIV Transmission

Phase: N/A Priority: Normal
NCT ID: NCT00001092 Org: User:
Start: 10/31/99 End: 10/31/08 Due: 10/31/09

Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02664415 Org: User:
Start: 08/31/16 End: 08/04/17 Due: 08/04/18

Prevention of GBS Colonization Via Immunity

Phase: N/A Priority: Normal
NCT ID: NCT00128219 Org: User:
Start: 07/31/03 End: 12/31/08 Due: 12/31/09

Evaluating the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid, Alone and in Combination, For Drug-Resistant Pulmonary Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT02583048 Org: User:
Start: 08/15/16 End: 02/04/21 Due: 02/04/22

Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30

Phase: N/A Priority: Normal
NCT ID: NCT02873260 Org: User:
Start: 08/31/16 End: 11/30/17 Due: 11/30/18

Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT03896750 Org: User:
Start: 03/27/24 End: 10/28/24 Due: 10/28/25

Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity

Phase: N/A Priority: Normal
NCT ID: NCT06169150 Org: User:
Start: 01/12/24 End: 10/01/43 Due: 10/01/44

Phase I Trial of Smallpox Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00046397 Org: User:
Start: 09/30/02 End: 08/31/05 Due: 08/31/06

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05917522 Org: User:
Start: 12/07/23 End: 07/31/29 Due: 07/31/30

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

Phase: N/A Priority: Normal
NCT ID: NCT05096091 Org: User:
Start: 08/16/21 End: 01/31/26 Due: 01/31/27

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02231879 Org: User:
Start: 10/14/14 End: 02/24/21 Due: 02/24/22

A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00001111 Org: User:
Start: - End: - Due: -

Zinc and Pneumonia Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00133432 Org: User:
Start: 09/30/05 End: - Due: -

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02028403 Org: User:
Start: 06/30/14 End: 11/30/15 Due: 11/30/16

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Phase: N/A Priority: Normal
NCT ID: NCT01336699 Org: User:
Start: 01/07/13 End: 05/12/15 Due: 05/12/16

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Phase: N/A Priority: Normal
NCT ID: NCT04761822 Org: User:
Start: 04/07/21 End: 04/27/22 Due: 04/27/23

Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis

Phase: N/A Priority: Normal
NCT ID: NCT01593722 Org: User:
Start: 04/30/12 End: 01/31/14 Due: 01/31/15

Cockroach Nasal Allergen Challenge Pilot

Phase: N/A Priority: Normal
NCT ID: NCT02710136 Org: User:
Start: 02/29/16 End: 04/11/17 Due: 04/11/18

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Phase: N/A Priority: Normal
NCT ID: NCT00001132 Org: User:
Start: 11/30/99 End: 04/30/01 Due: 04/30/02

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00016718 Org: User:
Start: 08/31/01 End: 01/31/09 Due: 01/31/10

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00004800 Org: User:
Start: 09/30/92 End: - Due: -

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00107549 Org: User:
Start: - End: 02/28/09 Due: 02/28/10

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Phase: N/A Priority: Normal
NCT ID: NCT00038987 Org: User:
Start: 05/31/02 End: 08/31/02 Due: 08/31/03

H5 Vaccine Alone or With Adjuvant in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00296634 Org: User:
Start: 03/31/06 End: 12/31/06 Due: 12/31/07